Clinical Trial Update: Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries [NA]

View source ↗

Summary

A clinical trial update evaluating preemptive intravenous micro-dose dexmedetomidine to prevent emergence agitation in adult patients undergoing septoplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emergence Agitation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Tanta University | Conditions: Emergence Agitation | NA | Status: NOT_YET_RECRUITING